# ctDNA Guided Treatment of Early Resistance to Targeted Treatment

> **NCT04148066** · NA · COMPLETED · sponsor: **The Netherlands Cancer Institute** · enrollment: 104 (actual)

## Conditions studied

- Carcinoma, Non-Small-Cell Lung

## Interventions

- **DIAGNOSTIC_TEST:** ctDNA blood sample

## Key facts

- **NCT ID:** NCT04148066
- **Lead sponsor:** The Netherlands Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-07-17
- **Primary completion:** 2021-12-17
- **Final completion:** 2021-12-17
- **Target enrollment:** 104 (ACTUAL)
- **Last updated:** 2023-10-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04148066

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04148066, "ctDNA Guided Treatment of Early Resistance to Targeted Treatment". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04148066. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*